FTO and neoplasm: The compelling evidence clearly indicates a role for FTO in cancer, yet although FTO has been described to remove m6A in the mRNA of tumour suppressors or genes that could confer resistance to immunotherapy, currently there is insufficient evidence to confirm that the effects detected in cancer are due exclusively to its demethylase activity.